AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2004 FEB 5 - (NewsRx.com & NewsRx.net) -- William F. Coffin, 818-789-0100
Mentor Corp. (MNT) responded to the new draft guidance document for breast implant sponsors that the U.S. Food and Drug Administration (FDA) released.
Chris Conway, CEO of Mentor Corp., stated, "We are not surprised that the FDA has taken this step to obtain additional information for its review of breast implant marketing applications. This is an important review which has generated considerable public interest. We have stated previously our view that the FDA review of silicone gel breast implants would be methodical and thorough, involving intense scrutiny of all available scientific data. It was apparent at the October panel meeting that some of the questions raised by public participants and panel members were not completely answered by the data presented. The FDA is now taking steps to ensure that the appropriate data becomes available for ...